JACC: Basic to Translational Science (Jun 2017)

Lipoprotein(a)-Associated Molecules Are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis

  • Michael Torzewski, MD,
  • Amir Ravandi, MD, PhD,
  • Calvin Yeang, MD, PhD,
  • Andrea Edel, PhD,
  • Rahul Bhindi, MD,
  • Stefan Kath, MD,
  • Laura Twardowski, MD,
  • Jens Schmid, PhD,
  • Xiaohong Yang, BS,
  • Ulrich F.W. Franke, MD,
  • Joseph L. Witztum, MD,
  • Sotirios Tsimikas, MD

Journal volume & issue
Vol. 2, no. 3
pp. 229 – 240

Abstract

Read online

Summary: The LPA gene is the only monogenetic risk factor for calcific aortic valve stenosis (CAVS). Oxidized phospholipids (OxPL) and lysophosphatidic acid generated by autotaxin (ATX) from OxPL are pro-inflammatory. Aortic valve leaflets categorized pathologically from both ATX–apolipoprotein B and ATX–apolipoprotein(a) were measureable in plasma. Lipoprotein(a) (Lp[a]), ATX, OxPL, and malondialdehyde epitopes progressively increased in immunostaining (p < 0.001 for all). Six species of OxPL and lysophosphatidic acid were identified after extraction from valve leaflets. The presence of a constellation of pathologically linked, Lp(a)-associated molecules in plasma and in aortic valve leaflets of patients with CAVS suggest that Lp(a) is a key etiologic factor in CAVS. Key Words: aortic valve stenosis, autotaxin, inflammation, Lp(a), oxidation-specific epitopes